Bruce Jason Tromberg

Bruce Jason Tromberg

Auto-generated profile, based on publicly available information

Bruce Jason Tromberg

University of California, Beckman Laser Institute and Medical Clinic, Irvine, California

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
DCDavid J. Cuccia
David J. Cuccia
FBFrédéric P. Bevilacqua
Frédéric P. Bevilacqua
ADAnthony Joseph Durkin
Anthony Joseph Durkin
FAFrederick R. Ayers
Frederick R. Ayers
BTBruce Jason Tromberg
Bruce Jason Tromberg
Light transport in tissues is a complex process due to multiple scattering and absorption. Thus, at the core of every optical technique for quantitative tissue characterization is the ability to separate optical absorption from optical scattering effects by the detection of a remitted or transmitted light field. This remission (or transmission) is a function of time and space, yielding two general classes of quantitative techniques: time-resolved and spatially resolved measurements, respectively (see Fig. 1 ). Time-resolved measurements are further broken down into time-domain and frequency-domain techniques: the first measuring the temporal point-spread function (t-PSF) , or spreading of a propagating pulse in time,1, 2 and the latter measuring the temporal modulation transfer function (t-MTF) , or the attenuation and phase delay of a periodically varying photon density wave.3, 4, 5 The time domain and frequency domain share an exact Fourier transform equivalency, although each has its trade-offs when considering real-life hardware and model-fitting constraints.

1 March 2015 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
RWRobert H. Wilson
Robert H. Wilson
KNKyle P. Nadeau
Kyle P. Nadeau
FJFrank B. Jaworski
Frank B. Jaworski
BTBruce J. Tromberg
Bruce J. Tromberg
ADAnthony J. Durkin
Anthony J. Durkin
We present a review of short-wave infrared (SWIR, defined here as ∼1000 to 2000 nm) spectroscopy and imaging techniques for biological tissue optical property characterization. Studies indicate notable SWIR absorption features of tissue constituents including water (near 1150, 1450, and 1900 nm), lipids (near 1040, 1200, 1400, and 1700 nm), and collagen (near 1200 and 1500 nm) that are much more prominent than corresponding features observed in the visible and near-infrared (VIS-NIR, defined here as ∼400 to 1000 nm). Furthermore, the wavelength dependence of the scattering coefficient has been observed to follow a power-law decay from the VIS-NIR to the SWIR region. Thus, the magnitude of tissue scattering is lower at SWIR wavelengths than that observed at VIS or NIR wavelengths, potentially enabling increased penetration depth of incident light at SWIR wavelengths that are not highly absorbed by the aforementioned chromophores. These aspects of SWIR suggest that the tissue spectroscopy and imaging in this range of wavelengths have the potential to provide enhanced sensitivity (relative to VIS-NIR measurements) to chromophores such as water and lipids, thereby helping to characterize changes in the concentrations of these chromophores due to conditions such as atherosclerotic plaque, breast cancer, and burns.

1 January 2006 in Journal of Biomedical Optics
Verified
Journal Article
Closed access
PDF file
ACAlbert E. Cerussi
Albert E. Cerussi
NSNatasha S. Shah
Natasha S. Shah
DHDavid Hsiang
David Hsiang
ADAmanda Durkin
Amanda Durkin
JBJohn A. Butler
John A. Butler
BTBruce Jason Tromberg
Bruce Jason Tromberg
Diffuse optical imaging (DOI) may be a beneficial diagnostic method for women with mammographically dense breast tissue. In order to evaluate the utility of DOI, we are developing broadband diffuse optical spectroscopy (DOS) to characterize the functional origins of optical signals in breast cancer patients. Broadband DOS combines multifrequency intensity-modulated and continuous-wave near-infrared light to quantify tissue absorption and scattering spectra from 650 to 1000 nm. Values of intrinsic physiological properties (oxy- and deoxy-hemoglobin, water, lipid, and scatter power) derived from absorption and scattering spectra provide detailed information on breast physiology. We present the results of clinical studies of 58 stage II/III malignant breast tumors using a noninvasive, handheld, broadband DOS probe. On average, eight positions were scanned over tumor and contralateral normal breast for each subject. Intrinsic physiological properties were statistically significantly different for malignant vs. normal tissues for all subjects, without patient age or tumor size/type stratification. Breast tissues containing malignant tumors displayed reduced lipid content (~20%) and increased water, deoxy-, and oxy-hemoglobin (<50% each) compared to normal breast tissues. Functional perturbations by the tumor were significantly larger than functional variations in normal tissues. A tissue optical index (TOI) derived from intrinsic physiological properties yielded an average two-fold contrast difference between malignant tumors and intrinsic tissue properties. Our results demonstrate that intrinsic optical signals can be influenced by functional perturbations characteristic of malignant transformation; cellular metabolism, extracellular matrix composition, and angiogenesis. Our findings further underscore the importance of broadband measurements and patient age stratification in breast cancer DOI.

6 March 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ACAlbert Cerussi
Albert Cerussi
DHDavid Hsiang
David Hsiang
NSNatasha Shah
Natasha Shah
RMRita Mehta
Rita Mehta
ADAmanda Durkin
Amanda Durkin
BTBruce J. Tromberg
Bruce J. Tromberg
Diffuse optical spectroscopy (DOS) and imaging are emerging diagnostic techniques that quantitatively measure the concentration of deoxy-hemoglobin (ctHHb), oxy-hemoglobin (ctO 2 Hb), water (ctH 2 O), and lipid in cm-thick tissues. In early-stage clinical studies, diffuse optical imaging and DOS have been used to characterize breast tumor biochemical composition and monitor therapeutic response in stage II/III neoadjuvant chemotherapy patients. We investigated whether DOS measurements obtained before and 1 week into a 3-month adriamycin/cytoxan neoadjuvant chemotherapy regimen can predict final, postsurgical pathological response. Baseline DOS measurements of 11 patients before therapy revealed significant increases in tumor ctHHb, ctO 2 Hb, ctH 2 O, and spectral scattering slope, and decreases in bulk lipids, relative to normal breast tissue. Tumor concentrations of ctHHb, ctO 2 Hb, and ctH 2 O dropped 27 ± 15%, 33 ± 7%, and 11 ± 15%, respectively, within 1 week (6.5 ± 1.4 days) of the first treatment for pathology-confirmed responders ( n = 6), whereas nonresponders ( n = 5) and normal side controls showed no significant changes in these parameters. The best single predictor of therapeutic response 1 week posttreatment was ctHHb (83% sensitivity, 100% specificity), while discrimination analysis based on combined ctHHb and ctH 2 O changes classified responders vs. nonresponders with 100% sensitivity and specificity. In addition, the pretreatment tumor-to-normal ctO 2 Hb ratio was significantly higher in responders (2.82 ± 0.44) vs. nonresponders (1.82 ± 0.49). These results highlight DOS sensitivity to tumor cellular metabolism and biochemical composition and demonstrate its potential for predicting and monitoring an individual's response to treatment.

28 November 2005 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
BTBruce J Tromberg
Bruce J Tromberg
ACAlbert Cerussi
Albert Cerussi
NSNatasha Shah
Natasha Shah
MCMontana Compton
Montana Compton
ADAmanda Durkin
Amanda Durkin
RMRita Mehta
Rita Mehta
Diffuse optical spectroscopy (DOS) and diffuse optical imaging (DOI) are non-invasive diagnostic techniques that employ near-infrared (NIR) light to quantitatively characterize the optical properties of centimeter-thick, multiple-scattering tissues. Although NIR was first applied to breast diaphanography more than 70 years ago, quantitative optical methods employing time- or frequency-domain 'photon migration' technologies have only recently been used for breast imaging. Because their performance is not limited by mammographic density, optical methods can provide new insight regarding tissue functional changes associated with the appearance, progression, and treatment of breast cancer, particularly for younger women and high-risk subjects who may not benefit from conventional imaging methods. This paper reviews the principles of diffuse optics and describes the development of broadband DOS for quantitatively measuring the optical and physiological properties of thick tissues. Clinical results are shown highlighting the sensitivity of diffuse optics to malignant breast tumors in 12 pre-menopausal subjects ranging in age from 30 to 39 years and a patient undergoing neoadjuvant chemotherapy for locally advanced breast cancer. Significant contrast was observed between normal and tumor regions of tissue for deoxy-hemoglobin (p = 0.005), oxy-hemoglobin (p = 0.002), water (p = 0.014), and lipids (p = 0.0003). Tissue hemoglobin saturation was not found to be a reliable parameter for distinguishing between tumor and normal tissues. Optical data were converted into a tissue optical index that decreased 50% within 1 week in response to neoadjuvant chemotherapy. These results suggest a potential role for diffuse optics as a bedside monitoring tool that could aid the development of new strategies for individualized patient care.

1 July 2012 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
TOThomas D. O’sullivan
Thomas D. O’sullivan
ACAlbert E. Cerussi
Albert E. Cerussi
DCDavid J. Cuccia
David J. Cuccia
BTBruce J. Tromberg
Bruce J. Tromberg
The authors describe the development of diffuse optical imaging (DOI) technologies, specifically the use of spatial and temporal modulation to control near infrared light propagation in thick tissues. We present theory and methods of DOI focusing on model-based techniques for quantitative, in vivo measurements of endogenous tissue absorption and scattering properties. We specifically emphasize the common conceptual framework of the scalar photon density wave for both temporal and spatial frequency-domain approaches. After presenting the history, theoretical foundation, and instrumentation related to these methods, we provide a brief review of clinical and preclinical applications from our research as well as our outlook on the future of DOI technology.